USANA Health Sciences, Inc. provided earnings guidance for the third quarter of 2021. For the quarter, the company currently anticipates net sales to range between $265 million and $270 million, which compares with $299 million in the prior-year period. Earnings per share for the quarter are expected to range between $1.28 and $1.33, which compares with $1.44 during the third quarter of 2020.